Also, if the patient is on other medications that cause gastrointestinal issues or vomiting, she may decide not to add a GLP-1, which can exacerbate these side effects
They do not need clinical trials proving effectiveness
As a result, they are less likely to lead to dependence or have withdrawal symptoms after you use them
Periodic B12 checks may be considered, especially if anemia, numbness, tingling, or nerve symptoms develop
Important safety information: Retatrutide is an investigational medication that has not been approved by the MHRA
The risk is greater when semaglutide is used with insulin or an insulin secretagogue such as a sulfonylurea